ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ENvue Medical's operating income for the twelve months ending Jun 30, 2026 was -$26.25M. For fiscal 2025 it was -$22.89M. The highest annual figure on record is -$1.21M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.89M | – |
| FY2024 | Dec 31, 2024 | -$3.58M | – |
| FY2023 | Dec 31, 2023 | -$3.44M | – |
| FY2022 | Dec 31, 2022 | -$5.01M | – |
| FY2021 | Dec 31, 2021 | -$5.68M | – |
| FY2020 | Dec 31, 2020 | -$4.72M | – |
| FY2019 | Dec 31, 2019 | -$5.15M | – |
| FY2018 | Dec 31, 2018 | -$4.30M | – |
| FY2017 | Dec 31, 2017 | -$3.09M | – |
| FY2016 | Dec 31, 2016 | -$2.32M | – |
| FY2015 | Dec 31, 2015 | -$1.42M | – |
| FY2014 | Dec 31, 2014 | -$1.21M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.71M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.25M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$970.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$674.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$568.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$702.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$670.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.01M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$924.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.27M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$868.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$991.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$804.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$907.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$793.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$896.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.36M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.33M | – |
| Q2 FY2018 | Jun 30, 2018 | -$825.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$790.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.02M | – |
| Q3 FY2017 | Sep 30, 2017 | -$613.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$660.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$802.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$456.00K | – |
See a number that looks wrong?